IREN
IREN Limited
There isn't enough reported data to score IREN yet.
STEX
Streamex Corp.
There isn't enough reported data to score STEX yet.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
STEX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| N/A | |
| N/A |
STEX's profitability is currently weak. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like STEX.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
STEX PE Valuation
STEX has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 6.3x next year's earnings.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
STEX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect STEX to return to profit, with revenue growing.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
STEX has the stronger earnings trend. Trailing diluted EPS is down 347% for IREN versus STEX down 223%.
STEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.05 | — |
| Q3 2022 | -$7.13 | +$3.07 |
| Q2 2022 | -$7.90 | +$4.00 |
| Q1 2022 | -$8.99 | +$7.71 |
| Q4 2021 | -$9.58 | +$9.12 |
| Q3 2021 | -$10.20 | +$12.30 |
| Q2 2021 | -$11.90 | +$9.30 |
| Q1 2021 | -$16.70 | +$1.10 |
| Q4 2020 | -$18.70 | -$2.20 |
STEX is still losing money, but far less than before: $8.74 per share over the past year, against $22.50 at its worst in late 2020.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
STEX has the stronger quarterly revenue trend. Revenue is down 5.1% for IREN versus up 1,015% for STEX.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN has the edge over STEX on profitability, with a higher operating margin.
STEX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $13K | +8.3% |
| Q1 2024 | $14K | +180% |
| Q4 2023 | $12K | -91% |
| Q3 2023 | $1K | -99% |
| Q1 2023 | $5K | -38% |
| Q4 2022 | $135K | +1588% |
| Q3 2022 | $135K | +25% |
| Q2 2022 | $8K | -96% |
STEX's revenue is recovering but still below its 2021 peak: $145,000 last quarter, up 1015% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12397% | N/A |
| Q2 2026 | -10384% | N/A |
| Q4 2024 | -9100% | +42292 points |
| Q2 2024 | -40708% | N/A |
| Q1 2024 | -24550% | +123170 points |
| Q4 2023 | -51392% | -46208 points |
| Q3 2023 | -405100% | -400296 points |
| Q1 2023 | -147720% | -46908 points |
STEX's operating margin was −12397% last quarter, up 12153 points from the same quarter a year ago.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
STEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.1M | -$1.1M |
| Q2 2026 | -$11.7M | -$10.5M |
| Q1 2026 | -$10.2M | -$9.1M |
| Q4 2023 | -$2.9M | +$1.2M |
| Q3 2023 | -$3.9M | +$1.1M |
| Q2 2023 | -$5M | +$1.7M |
| Q1 2023 | -$5.7M | +$303K |
| Q4 2022 | -$4.2M | +$1.7M |
STEX has the edge over IREN on cash flow, with more consistent year-over-year improvement.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has the edge over STEX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
STEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +3.3M shares |
| 1 year | +569% | +158M shares |
| 3 years | +2672% | +179M shares |
| 5 years | +6542% | +183M shares |
STEX has 185M diluted shares, up 569% from a year ago.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
STEX Net Leverage
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
STEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.5 | Neutral |
| Stochastic | 2.9 | Oversold |
STEX's weekly RSI is 34 (neutral) and its Stochastic is 3 (oversold).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
STEX PE vs Financial Services Sector
STEX has no meaningful PE right now: it lost money over the past year.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has stronger trend alignment. IREN is above 1 of 5 weekly averages versus STEX above 0 of 3.
STEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.46 | 33% below |
| 20 week MA | $0.66 | 53% below |
| 50 week MA | $1.52 | 80% below |
STEX is in a downtrend: it's below all three of its weekly moving averages, and 80% below its 50-week average.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN has the edge over STEX on returns for 2026, with the stronger performance.
STEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $6.27 | $3.14 | -50% |
| 2026 YTD | $3.14 | $0.31 | -90% |
STEX has finished every year since 2025 lower, and it's down 90% so far in 2026.